Aceclofenac EP Impurity B
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

15307-78-5Aceclofenac EP Impurity B

● Auf Lager

Katalog-Nr.::VL284005
CAS-Nr.::15307-78-5
Summenformel::C15H13Cl2NO2
Molare Masse::310.18 g/mol

Online bestellen

Einheit Preis Menge Status Aktion
100 mg $199.00
● Auf Lager
Wir akzeptieren Credit Card Icons

Zusätzliche Informationen zu CAS 15307-78-5

Parent drug

Aceclofenac

IUPAC-Name

Methyl [2-[(2,6-dichlorophenyl)amino]phenyl]acetate

Pharmacopeial Synonyms

N/A

Synonyme

Diclofenac-methyl ester

SMILES

O=C(OC)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl

InChI

InChI=1S/C15H13Cl2NO2/c1-20-14(19)9-10-5-2-3-8-13(10)18-15-11(16)6-4-7-12(15)17/h2-8,18H,9H2,1H3

Shipping Condition

Ambient Temperature

Beschreibung

Cytarabine EP Impurity H (HCl Salt), also known as Cyclocytidine hydrochloride ;Ancitabine hydrochloride ; 2,2′-O-Cyclocytidine hydrochloride is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Cytarabine. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications.“ Aceclofenac EP Impurity B (CAS No: 15307-78-5) or Aceclofenac Impurity B / Diclofenac Methyl Ester is a degradation product of Aceclofenac that reduces joint inflammation, pain intensity, and the duration of morning stiffness in rheumatoid arthritis patients.

References

Karbhari, PradnyaA, et al. “RP-LC Gradient Elution Method for Simultaneous Determination of Thiocolchicoside, Aceclofenac and Related Impurities in Tablet Formulation.” Journal of Pharmacy and Bioallied Sciences, vol. 6, no. 4, 2014, p. 246, https://doi.org/10.4103/0975-7406.142955. Dooley, Mukta, et al. “Aceclofenac.” Drugs, vol. 61, no. 9, 2001, pp. 1351–78, https://doi.org/10.2165/00003495-200161090-00012.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url